For the year ending 2025-12-31, BMEA had -$2,467K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -61,797 |
| Depreciation expense | 1,409 |
| Non-cash operating lease expense | 1,847 |
| Stock-based compensation expense | 9,520 |
| Change in fair value of warrant liability | -19,857 |
| Impairment of long-lived assets | 2,205 |
| Prepaid expenses and other current assets | -7,815 |
| Other non-current assets | -619 |
| Accounts payable | -9,700 |
| Accrued expenses and other current liabilities | -255 |
| Operating lease liabilities | -2,177 |
| Net cash used in operating activities | -70,371 |
| Proceeds from issuance of common stock under at the market equity offering program, net of offering costs | 4,908 |
| Proceeds from issuance of common stock, common warrants and pre-funded warrants, net of offering costs | 62,837 |
| Proceeds from stock options exercised and purchases under the employee stock purchase plan | 159 |
| Net cash provided by financing activities | 67,904 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -2,467 |
| Cash, cash equivalents, and restricted cash at the beginning of the period | 58,648 |
| Cash, cash equivalents, and restricted cash at the end of the period | 56,181 |
Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc. (BMEA)